SEARCH
GLOBAL DATABASE
| Companies recently added(a) updated(u): | Database Listed: 7694 | Feb 09, 2010 | Time: 07:46 | |||
| 06:30 u | ||||||
| 07:19 u | ||||||
| 11:14 u | ||||||
| 08:30 u | ||||||
| 08:38 u | ||||||
CUTTING EDGE COMPANIES IN THE NEWS
|
| February 6, 2010 |
[OneMedForum] Clarient Grows Along with Cancer Testing Market |
|
| February 1, 2010 |
[OneMedForum] BioSante Pharmaceuticals |
|
| January 31, 2010 |
LifeTech Capital Recommends NovaBay Pharmaceuticals |
| OraMed Pharmaceuticals and Its Oral Insulin PillOramed Pharmaceuticals in Jerusalem is developing a product that could potentially revolutionize the way diabetes is treated. |
| [OneMedForum] Amarantus Therapeutics: MANF on a MissionSunnyville, Calif.-based Amarantus Therapeutics is developing therapies to reverse the process of apoptosis. |
| [OneMedForum] Alexza Pharmaceuticals’ Pipeline Is Built for SpeedAlexza Pharmaceuticals of Mountain View, Calif., is focused on the development of inhalation drugs for the treatment of central nervous system disorders. |
| [OneMedForum] Senesco Technologies: Life and Death on a Cellular Level“Programmed cell death” sounds a bit sinister, but it’s actually a normal and healthy process. |
| [OneMedForum] Micrus Endovascular: Help for Stroke PatientsMicrus Endovascular is the only publicly traded company focused on strokes. |
| Sinus Patients May Benefit from Surgery, Study FindsA new study by Oregon Health and Science University indicates that minimally invasive surgery can significantly benefit adults with chronic sinusitis. |
| Diabetes Drug Wins Approval, Helps the CompetitionThe approval of Novo Nordisk’s diabetes drug Victoza has led to an unintended benefit for a competitor. |




























